>>> US Close Dow+0,13% S&P+0,03% Nasdaq-0,11%

Closing Market Summary: Stocks Begin Trading Week on Unassuming Note

The stock market began the last week of July on a quiet note with the S&P 500 ending less than a point above its flat line. Like the benchmark index, the Dow Jones Industrial Average (+0.1%) also posted a slim gain, while the Russell 2000 (-0.5%) and Nasdaq Composite (-0.1%) lagged throughout the session.

The major averages were awakened from their weekend slumber with an opening retreat that pressured the S&P 500 below its 20-day moving average (1975). Even though the index dipped early, only two sectors—consumer staples (-0.5%) and industrials (-0.5%)—displayed noteworthy weakness that persisted into the close.

Meanwhile, most of the remaining sectors kept pace with the broader market and climbed to highs as the afternoon wore on. The consumer discretionary sector (+0.2%) was an early laggard, but ended among the leaders with help from the likes of Netflix (NFLX 424.66, +2.80) and Priceline.com (PCLN 1239.29, +11.51). Furthermore, the sector drew strength from the retail industry, where Family Dollar (FDO 75.74, +15.08) agreed to be acquired by Dollar Tree (DLTR 54.87, +0.65) for $74.50/share, representing a 22.8% premium to Friday's closing price.

M&A activity was also the focus in another influential sector—technology (+0.2%)—with Zillow (Z 160.32, +1.46) acquiring Trulia (TRLA 65.04, +8.69) for $3.50 billion in stock, which represents roughly a 25.3% premium to Friday's closing price.

Elsewhere among tech shares, the largest sector component—Apple (AAPL 99.02, +1.35)—rallied 1.4%, but high-beta chipmakers were not nearly as fortunate. The PHLX Semiconductor Index shed 0.1% after being down as much as 1.3% during the opening hour of action.

Similar to chipmakers, biotech stocks struggled throughout the session, and while their underperformance weighed on the Nasdaq Composite, it had little impact on the health care sector. The iShares Nasdaq Biotechnology ETF (IBB 251.91, -2.15) lost 0.9%, while the health care sector tacked on 0.1%.

Like health care, countercyclical telecom services (+0.5%) and utilities (+1.5%) also finished in the green. Notably, the utilities sector climbed throughout the session to extend its year-to-date advance to 13.3%.

On the fixed income side, the 10-yr note made a brief appearance in the green when equities were on their lows, before sliding to a fresh low ahead of the close. The benchmark note shed four ticks with its yield climbing two basis points to 2.48%.

Participation was below average with less than 580 million shares changing hands at the NYSE.

Economic data was limited to the Pending Home Sales report for June:

* Pending home sales fell 1.1% in June, which was worse than the 0.8% decrease forecast by the Briefing.com consensus 

* The May reading was revised down to 6.0% from 6.1% 

Tomorrow, the Case-Shiller 20-City Index for May (consensus 10.0%) will be released at 9:00 ET, while July Consumer Confidence (consensus 85.6) will cross the wires at 10:00 ET. On the earnings front, BP (BP 50.64, -0.28), Honda Motor (HMC 35.18, +0.19), Pfizer (PFE 30.10, -0.09), and UPS (UPS 102.66, -0.91) will report their results ahead of the opening bell.

* S&P 500 +7.1% YTD  * Nasdaq Composite +6.4% YTD  * Dow Jones Industrial Average +2.5% YTD  * Russell 2000 -2.1% YTD

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: CRNT -6.2% (also announces public offering of its ordinary share), SOHU -5.6%, HIHO -4.2%, SKYW -3.6%, TSN -1.4%, CYOU -0.6%, CMI -0.5%, TGE -0.4%.

M&A news: DG DG -2.9% (potentially related to FDO/DLTR news, less likely to be acquired), BRKR -2.6% (announces acquisition of Vutara)

Select solar names showing weakness after news that US has decided on new anti-dumping duties on imports of solar products from China: JKS -4.1%, YGE -4%, CSIQ -3.4%, JASO -2.5%, TSL -2.3%.

Other news: HZNP -36% (disclosed that it has been notified that in August 2014 CVS Caremark (CVS) and Express Scripts (ESRX) expect to announce DUEXIS and VIMOVO will no longer be on their formularies), ACRX -26.8% (receives Complete Response Letter from FDA for New Drug Application for Zalviso), JMEI -8.3% (no known catalyst, pulling back following recent strength), TRLA-5.1% (cautious Citron report out over the weekend), RBS -3.1% (plans to sell Ulster Bank stake, according to reports), BIOD -2.9% (enters into $15 mln equity commitment with Lincoln Park Capital), YNDX -1.8% (Russian Micex down 1%), BLDR -1.7% (negative mention Mad Money), CCL -1.1% (still checking), SDRL -0.9% (announces result of voluntary incentive offer to convert the $650 mln of 3.375% 2017 convertible bond), DNKN -0.7% (negative mention Mad Money), Z -0.6% (cautious Citron report out over the weekend), BSX -0.5% (JNJ and BSX dispute over deal to go to trail, according to reports), .

Analyst comments: TRP -1.5% (downgraded to Neutral from Outperform at Credit Suisse), MNST -1.4% (downgraded to Neutral from Buy at UBS), PCG -1.2% (upgraded to Buy from Neutral at Goldman), CSCO -0.9% (downgraded to Sector Perform from Outperform at Pacific Crest), EE -0.9% (downgraded to Hold from Buy at Jefferies), PFE -0.5% (downgraded to Mkt Perform from Outperform at BMO Capital Mkts), COG -0.4% (downgraded to Perform at Oppenheimer).